Unusual and complicated peritonitis : Your questions answered

Effective treatment of infections is a growing challenge owing to antimicrobial resistance. Peritoneal dialysis (PD) patients experience more frequent hospitalisations than the general population and have greater exposure to antibiotics, making them particularly vulnerable to this threat. Over the last decade, we have noted a surge in cases of complicated peritoneal dialysis-associated peritonitis (PD peritonitis) caused by antimicrobial-resistant organisms, including extended-spectrum beta-lactamase (ESBL), AmpC beta-lactamase-producing Enterobacterales, Pseudomonas aeruginosa and fungi. Practitioners must be alert to these organisms, seek early recognition of these resistance patterns and make timely adjustments in order to avoid delay in treatment that may increase risk of PD catheter removal and technique failure. We present a case of successful treatment of ESBL peritonitis, highlight its challenges, while providing guidance on management of other unusual and complicated PD peritonitis.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - year:2024

Enthalten in:

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis - (2024) vom: 27. März, Seite 8968608241237400

Sprache:

Englisch

Beteiligte Personen:

Zheng, Sijia [VerfasserIn]
Bargman, Joanne M [VerfasserIn]

Links:

Volltext

Themen:

Antimicrobial resistance
Culture-negative peritonitis
ESBL
Fungal peritonitis
Journal Article
Mycobacterial peritonitis
Peritoneal dialysis
Peritonitis
Pseudomonas
Review

Anmerkungen:

Date Revised 27.03.2024

published: Print-Electronic

Citation Status Publisher

doi:

10.1177/08968608241237400

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM37022258X